NEWS Coronavirus News Delta Variant and Long COVID Are the Biggest Pandemic Issues, Experts Say By Valerie DeBenedette Valerie DeBenedette Valerie DeBenedette has over 30 years' experience writing about health and medicine. She is the former managing editor of Drug Topics magazine. Learn about our editorial process Updated on July 23, 2021 Fact checked by Angela Underwood Fact checked by Angela Underwood LinkedIn Angela Underwood's extensive local, state, and federal healthcare and environmental news coverage includes 911 first-responder compensation policy to the Ciba-Geigy water contamination case in Toms River, NJ. Her additional health-related coverage includes death and dying, skin care, and autism spectrum disorder. Learn about our editorial process Share Tweet Email Print Eoneren / Getty Images Key Takeaways The Delta variant has become the dominant strain of coronavirus in the U.S.Available vaccines are effective against the Delta variant, but the infection rate from the virus is expected to go up in the pockets of the country where vaccination rates are low.As more people become infected, more information is emerging about long COVID. About 30% of those who contract COVID-19 appear to have persistent symptoms. Last week, infectious diseases experts from the Johns Hopkins Bloomberg School of Public Health met to discuss two major public issues of the pandemic: the Delta variant and long-COVID. The July 14 media briefing came on the heels of Delta becoming the dominant COVID-19 strain in the United States. Immunity and the Delta Variant COVID-19 infection rates were lower in May and June than at any time since the start of the pandemic, said David Dowdy, MD, an associate professor of epidemiology at the Johns Hopkins Bloomberg School of Public Health. “This is largely attributable to vaccination, with nearly 60% of adults in the U.S. being fully vaccinated," Dowdy said at the briefing. "Of those who have not been [vaccinated], probably over a third have been infected and are also likely immune.” This means the majority of the population has a significant level of immunity against COVID-19, he added. In 13 States, Declining Demand for COVID Vaccines Threatens Herd Immunity But Dowdy said the number of reported cases has doubled in the last couple of weeks. Many of these cases are due to the Delta variant, which appears to be more easily transmitted than other strains and which has now become the dominant strain of virus in the United States. “It's hard to know how much of the current increasing cases is due to the variant versus changes in behavior as our society has opened up,” he said. “It doesn’t mean a major wave is inevitable.” What is clear, however, is that younger people—many of whom are unvaccinated—are at a higher risk for Delta. “The people who are getting infected now are not the same as people who were getting infected the beginning of the pandemic," Dowdy said. "They are younger and may have different contact networks." Although new variants may be more easily spread from person to person, they are not more likely to cause severe disease or death, Dowdy said. And for those who are able to get vaccinated, vaccines are still the best weapon against the variant. “It's important to note that there's no evidence that the current vaccines are any less effective against the Delta variant,” he said. “Vaccines still work and work very well.” 3 Things to Know About the Delta Variant, According to an Infectious Disease Expert The Prevalence of Long COVID Eighteen months ago, at the start of the pandemic, focus was on the mortality of COVID-19. Hospitals were overrun and large number of people were dying. Now that death rates are down, researchers can focus on morbidity—the experience of someone who is unwell because of COVID-19. “We now have what we call the chronic state of infection, and that's what we're starting to see emerge in very large numbers for COVID," Priya Duggal, PhD, professor of epidemiology at the Johns Hopkins Bloomberg School of Public Health, said at the media briefing, referring to long COVID. She says 30% of people with COVID-19 report symptoms that last more than 30 days and even up to a year after infection. According to Duggal, long COVID symptoms are varied and include prolonged loss of taste or smell, brain fog, anxiety, depression, heart problems, kidney conditions, excessive fatigue, and difficulty breathing. It's systemic, meaning many different organ systems can be affected. Long COVID “These are all real symptoms that we're starting to see across the age spectrum of individuals who are infected with COVID-19,” Duggal said. “What’s really interesting, and what is perhaps more devastating, is that we're also seeing it among those individuals who were mildly or moderately affected, and in some cases, those who were previously asymptomatic." About 5% of people say they have symptoms that are debilitating enough to interfere with their function in their daily life, she noted. ‘It’s Like Something Took My Kids Away’: How Chronic COVID Transformed a Family While Johns Hopkins is collecting information for a study of long COVID, Duggal said "we don't know what the numbers are supposed to tell us." Information collected so far shows that long COVID tends to affect younger people: those in their 30s, 40s, and 50s. Younger women are more likely to report lasting symptoms than younger men, but it is not known if there are any differences due to race, socioeconomic class, or to other diseases a person might have. “Until we get a handle on what the symptoms are and the spectrum of symptoms for long COVID, it's going to be difficult for healthcare workers to address,” Duggal said. What Is Long COVID? What This Means For You The Delta variant is likely to spread in areas of the country that have low vaccination rates. And while long COVID can occur in vaccinated individuals, the odds are slim. Getting vaccinated is the best way to protect again both infection with a COVID variant and becoming a long hauler. The information in this article is current as of the date listed, which means newer information may be available when you read this. For the most recent updates on COVID-19, visit our coronavirus news page. By Valerie DeBenedette Valerie DeBenedette has over 30 years' experience writing about health and medicine. She is the former managing editor of Drug Topics magazine. See Our Editorial Process Meet Our Medical Expert Board Share Feedback Was this page helpful? Thanks for your feedback! What is your feedback? Other Helpful Report an Error Submit